A prospective single-arm study on the efficacy and safety of short-course oral corticosteroids followed by topical corticosteroids in patients with severe chronic rhinosinusitis with nasal polyps

References

• Wang X, Zhang N, Bo M, et al. Diversity of T H cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania. J Allergy Clin Immunol. 2016;138(5):1344–1353. DOI:10.1016/j.jaci.2016.05.041
   PubMed Web of Science ®Google Scholar
• Fokkens WJ, Lund VJ, Hopkins C, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(1):1–464. DOI:10.4193/Rhin20.401.
   Web of Science ®Google Scholar
• Maggi E, Parronchi P, Azzarone BG, et al. A pathogenic integrated view explaining the different endotypes of asthma and allergic disorders. Allergy. 2022;77:3267–3292.
   PubMed Web of Science ®Google Scholar
• Lou H, Wang C, Zhang L. Endotype-driven precision medicine in chronic rhinosinusitis. Expert Rev Clin Immunol. 2019;15:1171–1183.
   PubMed Web of Science ®Google Scholar
• Dalziel K, Stein K, Round A, et al. Systematic review of endoscopic sinus surgery for nasal polypsVol. 7, (UK): Health technology assessment (Winchester; 2003. p. 1–159.
   Google Scholar
• Badia L, Lund V. Topical corticosteroids in nasal polyposis. Drugs. 2001;61:573–578.
   PubMed Web of Science ®Google Scholar
• Van Zele T, Gevaert P, Holtappels G, et al. Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol. 2010;125(5):1069–1076. DOI:10.1016/j.jaci.2010.02.020
   PubMed Web of Science ®Google Scholar
• Epperson MV, Phillips KM, Caradonna DS, et al. Predictors of efficacy for combination oral and topical corticosteroids to treat patients with chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 2019;9:1436–1442.
   PubMed Web of Science ®Google Scholar
• Orlandi RR, Kingdom TT, Smith TL, et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021;11(3):213–739. DOI:10.1002/alr.22741
   PubMed Web of Science ®Google Scholar
• Kirtsreesakul V, Wongsritrang K, Ruttanaphol S. Does oral prednisolone increase the efficacy of subsequent nasal steroids in treating nasal polyposis? Am J Rhinol Allergy. 2012;26(6):455–462. DOI:10.2500/ajra.2012.26.3820.
   PubMed Web of Science ®Google Scholar
• Alobid I, Benitez P, Cardelus S, et al. Oral plus nasal corticosteroids improve smell, nasal congestion, and inflammation in sino-nasal polyposis. Laryngoscope. 2014;124(1):50–56. DOI:10.1002/lary.24330
   PubMed Web of Science ®Google Scholar
• Benitez P, Alobid I, de Haro J, et al. A short course of oral prednisone followed by intranasal budesonide is an effective treatment of severe nasal polyps. Laryngoscope. 2006;116(5):770–775. DOI:10.1097/01.mlg.0000205218.37514.0f.
   PubMed Web of Science ®Google Scholar
• Bachert C, Marple B, Schlosser RJ, et al. Adult chronic rhinosinusitis. Nat Rev Dis Primers. 2020;6:86.
   PubMed Web of Science ®Google Scholar
• Ta NH, Hopkins C, Vennik J, et al. Optimising trial outcomes and patient retention for the MACRO trial for chronic rhinosinusitis. Rhinology. 2019;57:358–366.
   PubMed Web of Science ®Google Scholar
• Hopkins C, Hettige R, Soni-Jaiswal A, et al. Chronic Rhinosinusitis Outcome MEasures (CHROME), developing a core outcome set for trials of interventions in chronic rhinosinusitis. Rhinology. 2018;56:22–32. doi:10.4193/Rhin17.247.
   PubMed Web of Science ®Google Scholar
• Ting F, Hopkins C. Outcome Measures in Chronic Rhinosinusitis. Curr Otorhinolaryngol Rep. 2018;6:271–275.
   PubMedGoogle Scholar
• Bachert C, Peters AT, Heffler E, et al. Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient-reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS-24 and SINUS-52 studies. Clin Exp Allergy. 2022;52:244–249. doi:10.1111/cea.14051.
   PubMed Web of Science ®Google Scholar
• Ta NH, Gao J, Philpott C. A systematic review to examine the relationship between objective and patient-reported outcome measures in sinonasal disorders: recommendations for use in research and clinical practice. Int Forum Allergy Rhinol. 2021;11:910–923.
   PubMed Web of Science ®Google Scholar
• Fokkens WJ, Lund VJ, Mullol J, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl. 2012;23:1–298.
   Google Scholar
• Snidvongs K, Heller GZ, Sacks R, et al. Validity of European position paper on rhinosinusitis disease control assessment and modifications in chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2014;150:479–486.
   PubMed Web of Science ®Google Scholar
• Calus L, Van Bruaene N, Bosteels C, et al. Twelve-year follow-up study after endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyposis. Clin Transl Allergy. 2019;9:30.
   PubMed Web of Science ®Google Scholar
• Chowdhury NI, Mace JC, Bodner TE, et al. Investigating the minimal clinically important difference for SNOT-22 symptom domains in surgically managed chronic rhinosinusitis. Int Forum Allergy Rhinol. 2017;7:1149–1155.
   PubMed Web of Science ®Google Scholar
• Chowdhury NI, Mace JC, Bodner TE, et al. Does Medical Therapy Improve SinoNasal Outcomes Test-22 Domain Scores? An Analysis of Clinically Important Differences. Laryngoscope. 2019;129:31–36.
   PubMed Web of Science ®Google Scholar
• Yip J, Hao W, Eskander A, et al. Wait times for endoscopic sinus surgery influence patient-reported outcome measures in patients with chronic rhinosinusitis who fulfill appropriateness criteria. Int Forum Allergy Rhinol. 2019;9:396–401.
   PubMed Web of Science ®Google Scholar
• Gliklich RE, Metson R. Techniques for outcomes research in chronic sinusitis. Laryngoscope. 1995;105:387–390.
   PubMed Web of Science ®Google Scholar
• Hopkins C, Gillett S, Slack R, et al. Psychometric validity of the 22-item Sinonasal Outcome Test. Clinical Otolaryngology: Official Journal of ENT-UK; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery. 2009;34:447–454.
   PubMed Web of Science ®Google Scholar
• Benninger MS, Senior BA. The development of the rhinosinusitis disability index. Archives of otolaryngology–head & neck surgery. 1997;123(11):1175–1179.
   Google Scholar
• Phillips KM, Hoehle LP, Caradonna DS, et al. Minimal clinically important difference for the 22-item sinonasal outcome test in medically managed patients with chronic rhinosinusitis. Clinical Otolaryngology: Official Journal of ENT-UK; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery. 2018;43:1328–1334.
   PubMed Web of Science ®Google Scholar
• Phillips KM, Houssein FA, Boeckermann LM, et al. Multi-institutional minimal clinically important difference of the 22-item Sinonasal Outcome Test in medically managed chronic rhinosinusitis. Rhinology. 2021;59:552–559.
   PubMed Web of Science ®Google Scholar
• Mattos JL, Rudmik L, Schlosser RJ, et al. Symptom importance, patient expectations, and satisfaction in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2019;9:593–600.
   PubMed Web of Science ®Google Scholar
• Seys SF, De Bont S, Fokkens WJ, et al. Real-life assessment of chronic rhinosinusitis patients using mobile technology: the mySinusitiscoach project by EUFOREA. Allergy. 2020;75:2867–2878.
   PubMed Web of Science ®Google Scholar
• der Veen J V, Seys SF, Timmermans M, et al. Real-life study showing uncontrolled rhinosinusitis after sinus surgery in a tertiary referral centre. Allergy. 2017;72:282–290.
   PubMed Web of Science ®Google Scholar
• Bachert C, Han JK, Wagenmann M, et al. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: definitions and management. J Allergy Clin Immunol. 2021;147:29–36.
   PubMed Web of Science ®Google Scholar
• Bachert C, Han JK, Desrosiers M, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019;394:1638–1650.
   PubMed Web of Science ®Google Scholar
• Bachert C, Mannent L, Naclerio RM, et al. Effect Of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial. JAMA. 2016;315:469–479.
   PubMed Web of Science ®Google Scholar
• Kalayci O, Yorgancioglu A, Kalyoncu F, et al. Allergic rhinitis and its impact on asthma update (ARIA 2008): the Turkish perspective. Turk J Pediatr. 2008;50:307–312.
   PubMed Web of Science ®Google Scholar
• Gray LEK, Sly PD. Update in Asthma 2017. Am J Respir Crit Care Med. 2018;197(9):1108–1115.
   PubMed Web of Science ®Google Scholar
• Vaidyanathan S, Barnes M, Williamson P, et al. Treatment of chronic rhinosinusitis with nasal polyposis with oral steroids followed by topical steroids: a randomized trial. Ann Intern Med. 2011;154:293–302. DOI:10.7326/0003-4819-154-5-201103010-00003.
   PubMed Web of Science ®Google Scholar
• Krucoff MW, Jones WS. Performance goal criteria for device evaluation in lower extremity peripheral vascular intervention and the need for standardized data structure: what is the sound of one hand clapping? JACC Cardiovasc Interv. 2018;11(19):2004–2006.
   PubMed Web of Science ®Google Scholar
• Koreckij T, Kreiner S, Khalil JG, et al. Prospective, randomized, multicenter study of intraosseous basivertebral nerve ablation for the treatment of chronic low back pain: 24-Month treatment arm results. North American Spine Society Journal. 2021;8:100089.
   PubMedGoogle Scholar
• Singhatanadgige W, Chancharoenchai T, Honsawek S, et al. No difference in pain after spine surgery with local wound filtration of morphine and ketorolac: a randomized controlled trial. Clin Orthop Relat Res. 2020;478:2823–2829.
   PubMed Web of Science ®Google Scholar
• Bachert C, Hellings PW, Mullol J, et al. Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis. Allergy. 2020;75:148–157.
   PubMed Web of Science ®Google Scholar
• Foong WS, Zeng GJ, Goh GS, et al. Determining the minimal clinically important difference on the oxford shoulder instability score in patients undergoing arthroscopic bankart repair for shoulder instability. Orthop J Sports Med. 2022;10:23259671211060023. DOI:10.1177/23259671211060023.
   Web of Science ®Google Scholar
• Sedaghat AR. Understanding the Minimal Clinically Important Difference (MCID) of Patient-Reported Outcome Measures. Otolaryngology–head and neck surgery. Otolaryngology–Head and Neck Surgery. 2019;161(4):551–560.
   PubMed Web of Science ®Google Scholar
• Iwakura M, Okura K, Kubota M, et al. Estimation of minimal clinically important difference for quadriceps and inspiratory muscle strength in older outpatients with chronic obstructive pulmonary disease: a prospective cohort study. Phys Ther Res. 2021;24:35–42.
   PubMedGoogle Scholar
• Sobreira M, Almeida MP, Gomes A, et al. Minimal clinically important differences for measures of pain, lung function, fatigue, and functionality in spinal cord injury. Phys Ther. 2021;101:zaa210.
   Web of Science ®Google Scholar
• Meltzer EO, Wallace D, Dykewicz M, et al. Minimal Clinically Important Difference (MCID) in allergic rhinitis: agency for healthcare research and quality or anchor-based thresholds? The Journal of Allergy and Clinical Immunology in Practice. 2016;4(4):682–688. DOI:10.1016/j.jaip.2016.02.006
   PubMed Web of Science ®Google Scholar
• Muñoz-Leyva F, El-Boghdadly K, Chan V. Is the minimal clinically important difference (MCID) in acute pain a good measure of analgesic efficacy in regional anesthesia? Reg Anesth Pain Med. 2020;45:1000–1005.
   PubMed Web of Science ®Google Scholar
• Wu D, Yan B, Wang Y, et al. Charcot-Leyden crystal concentration in nasal secretions predicts clinical response to glucocorticoids in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2019;144(1):345–348. DOI:10.1016/j.jaci.2019.03.029
   PubMed Web of Science ®Google Scholar
• Hong H, Chen F, Sun Y, et al. Nasal IL-25 predicts the response to oral corticosteroids in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2018;141(5):1890–1892. DOI:10.1016/j.jaci.2017.10.050
   PubMed Web of Science ®Google Scholar
• Milara J, Peiró T, Armengot M, et al. Mucin 1 downregulation associates with corticosteroid resistance in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2015;135:470–476.
   PubMed Web of Science ®Google Scholar
• Milara J, Morell A, Ballester B, et al. MUC4 impairs the anti-inflammatory effects of corticosteroids in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2017;139(3):855–862. DOI:10.1016/j.jaci.2016.06.064
   PubMed Web of Science ®Google Scholar
• Leshin M. Acute adrenal insufficiency: recognition, management, and prevention. Urologic Clini North Am. 1982;9:229–235.
   PubMed Web of Science ®Google Scholar
• Ramsahai JM, King E, Niven R, et al. Serum prednisolone levels as a marker of oral corticosteroid adherence in severe asthma. BMC Pulm Med. 2020;20:228.
   PubMed Web of Science ®Google Scholar